Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Escherichia coli

ABSTRACT: Engineering of the ligand specificity of transcriptional regulator XylS by deep mutational scanning

PROVIDER: PRJDB12536 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR327403_1.fastq.gz	Fastqsanger.gz
	DRR327403_2.fastq.gz	Fastqsanger.gz
	DRR327404_1.fastq.gz	Fastqsanger.gz
	DRR327404_2.fastq.gz	Fastqsanger.gz
	DRR327405_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Escherichia coli strain:ER2566

Project description:E. Coli DHFR Deep Mutational Scanning

| PRJNA590072 | ENA

Escherichia coli

Project description:Mutational scanning of EcFbFP

| PRJNA242983 | ENA

Escherichia coli strain:Stellar (Clontech)

Project description:Comprehensive mutational scanning of an enzyme in vivo reveals activity- and specificity-determining residues

| PRJNA196551 | ENA

Deep mutational scanning of CYP2C19 reveals a substrate specificity-abundance tradeoff

Project description:Deep mutational scanning of CYP2C19 reveals a substrate specificity-abundance tradeoff

| PRJNA1023263 | ENA

A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins

Project description:Deep mutational scanning is a powerful method for exploring the mutational fitness landscape of proteins. Its adaptation to anti-CRISPR proteins, which are natural CRISPR-Cas inhibitors and key players in the co-evolution of microbes and phages, facilitates their characterization and optimization. Here, we developed a robust anti-CRISPR deep mutational scanning pipeline in Escherichia coli that combines synthetic gene circuits based on CRISPR interference with flow cytometry coupled sequencing and mathematical modeling. Using this pipeline, we characterized comprehensive single point mutation libraries for AcrIIA4 and AcrIIA5, two potent inhibitors of CRISPR-Cas9. The resulting mutational fitness landscapes revealed considerable mutational tolerance for both Acrs, suggesting an intrinsic redundancy with respect to Cas9 inhibitory features, and – for AcrIIA5 – indicated mutations that boost Cas9 inhibition. Subsequent in vitro characterization suggested that the observed differences in inhibitory potency between mutant inhibitors were mostly due to changes in binding affinity rather than protein expression levels. Finally, to demonstrate that our pipeline can inform Acrs-based genome editing applications, we employed a selected subset of mutant inhibitors to increase CRISPR-Cas9 target specificity by modulating Cas9 activity. Taken together, our work establishes deep mutational scanning as a powerful method for anti-CRISPR protein characterization and optimization.

2024-03-01 | GSE254101 | GEO

Project description:Deep mutational scanning of hOCT1

| PRJNA980726 | ENA

Project description:VIM-2 deep mutational scanning

| PRJNA606894 | ENA

CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli

Project description:Deep mutational scanning can provide significant insights into the function of essential genes in bacteria. Here, we developed a high-throughput method for mutating essential genes of Escherichia coli in their native genetic context. We used Cas9-mediated recombineering to introduce a library of mutations, created by error-prone PCR, within a gene fragment on the genome using a single gRNA pre-validated for high efficiency. Tracking mutation frequency through deep sequencing revealed biases in the position and the number of the introduced mutations. We overcame these biases by increasing the homology arm length and blocking mismatch repair to achieve a mutation efficiency of 85% for non-essential genes and 55% for essential genes. These experiments also improved our understanding of poorly characterized recombineering process using dsDNA donors with single nucleotide changes. Finally, we applied our technology to target rpoB, the beta subunit of RNA polymerase, to study resistance against rifampicin. In a single experiment, we validate multiple biochemical and clinical observations made in the previous decades and provide insights into resistance compensation with the study of double mutants.

2020-01-15 | GSE143629 | GEO

Project description:Deep Mutational Scanning of alpha-Synuclein

| PRJNA564806 | ENA

Project description:Type-1 myosin deep mutational scanning

| PRJNA1079703 | ENA